Jean Delwaide
Department of Hepato-Gastroenterology
CHU Sart Tilman
Université de Liège
Hospital Saint Joseph
Belgium
Name/email consistency: high
- HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin. Delwaide, J., Reenaers, C., Gerard, C., Vaira, D., Bastens, B., Servais, B., Bekhti, A., Bataille, C., Wain, E., De Leeuw, P., Daenen, G., Mesureur, T., Sente, J.M., Belaïche, J. Eur. J. Gastroenterol. Hepatol (2006)
- Hepatitis C infection: eligibility for antiviral therapies. Delwaide, J., El Saouda, R., Gérard, C., Belaïche, J. Eur. J. Gastroenterol. Hepatol (2005)
- Hepatitis C virus genotype 5 in southern belgium: epidemiological characteristics and response to therapy. Delwaide, J., Gerard, C., Reenaers, C., Vaira, D., Bastens, B., Bataille, C., Servais, B., Maes, B., Belaiche, J., Hepatotropes, G.L. Dig. Dis. Sci. (2005)
- Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response. Delwaide, J., Bourgeois, N., Gérard, C., De Maeght, S., Mokaddem, F., Wain, E., Bastens, B., Fevery, J., Géhénot, M., Le Moine, O., Martinet, J.P., Robaeys, G., Servais, B., Van Gossum, M., Van Vlierberghe, H. Aliment. Pharmacol. Ther. (2004)
- Postexposure management of hepatitis A, B or C: treatment, postexposure prophylaxis and recommendations. Delwaide, J. Acta Gastroenterol. Belg. (2003)
